Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Vivos Therapeutics (VVOS) Asset Utilization Ratio (2021 - 2025)

Vivos Therapeutics has reported Asset Utilization Ratio over the past 5 years, most recently at 0.69 for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 30.02% to 0.69 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.69 through Dec 2025, down 30.02% year-over-year, with the annual reading at 0.86 for FY2025, 25.34% down from the prior year.
  • Asset Utilization Ratio was 0.69 for Q4 2025 at Vivos Therapeutics, up from 0.67 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 1.31 in Q4 2023 and troughed at 0.36 in Q3 2021.
  • The 5-year median for Asset Utilization Ratio is 0.85 (2024), against an average of 0.83.
  • Year-over-year, Asset Utilization Ratio soared 120.75% in 2022 and then plummeted 30.02% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.45 in 2021, then soared by 120.75% to 1.0 in 2022, then soared by 31.44% to 1.31 in 2023, then decreased by 25.16% to 0.98 in 2024, then plummeted by 30.02% to 0.69 in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Asset Utilization Ratio are 0.69 (Q4 2025), 0.67 (Q3 2025), and 0.77 (Q2 2025).